Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) - Global Forecasts to 2026

世界の放射線療法市場予測:製品別、処置別、用途別、エンドユーザー別

◆タイトル:Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) - Global Forecasts to 2026
◆商品コード:MD1773
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年6月20日
◆ページ数:251
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は世界の放射線療法市場規模が2021年59億ドルから2026年73億ドルまで、年平均4.2%成長すると予想しています。本市場調査レポートでは、放射線療法の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(体外照射療法製品、内部ビーム放射線治療/近接照射療法製品、全身放射線療法)分析、用途別(外部ビーム放射線治療用、内部ビーム放射線治療/近接照射療法用)分析、処置別(体外照射療法、画像誘導放射線治療、内部ビーム放射線療法/小線源治療、全身放射線療法)分析、エンドユーザー別(病院、独立型放射線治療センター)分析、地域別分析、競争状況、企業情報など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の放射線療法市場規模:製品別(体外照射療法製品、内部ビーム放射線治療/近接照射療法製品、全身放射線療法)
・世界の放射線療法市場規模:用途別(外部ビーム放射線治療用、内部ビーム放射線治療/近接照射療法用)
・世界の放射線療法市場規模:処置別(体外照射療法、画像誘導放射線治療、内部ビーム放射線療法/小線源治療、全身放射線療法)
・世界の放射線療法市場規模:エンドユーザー別(病院、独立型放射線治療センター)
・世界の放射線療法市場規模:地域別
・競争状況
・企業情報

“The global radiotherapy market is valued at USD 5.9 billion in 2021 and is expected to reach USD 7.3 billion by 2026, at a CAGR of 4.2% during the forecast period.”
The growth of this market is primarily driven by the rising burden of target diseases and increasing investments, funds, and grants for the development of novel products. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of this market. However, the underdeveloped public health infrastructure in emerging countries, shortage of trained and skilled radiation oncologists, and the limited access to and affordability of various radiotherapy treatment options are the major factors that are expected to restrain the growth of this market during the forecast period.

“The prostate cancer segment, by application, accounted for the largest share of the external beam as well as internal beamradiotherapymarket in 2020.”
On the basis of application, the radiotherapy market is classified into two major segments—external beam radiotherapy and internal beam radiotherapy/brachytherapy applications. Based on indication, the external beam radiotherapy applications segment is further divided into prostate cancer, breast cancer, lung cancer, colorectal cancer, head and neck cancer (laryngeal cancer, hypopharyngeal cancer, oropharyngeal cancer, and oral cavity cancer), and other cancers (pancreatic cancer, brain cancer, and gastrointestinal cancer, among others). The prostate cancer segment accounted for a significant share of both EBRT and brachytherapy market owing to the high and growing prevalence of prostate cancer and the positive outcomes for prostate cancer treatment usingradiotherapy.

“The particle therapy segment ofproduct, to register a significant growth rate amongst the external beam radiotherapy products, owing to new product launches and approvals.”
On the basis of product, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy products. The external beam radiotherapy products segment is further divided into linear accelerators, particle therapy systems, and conventional cobalt-60 teletherapy units. The internal beam radiotherapy/brachytherapy products segment includes seeds, applicators, afterloaders, and IORT systems, while the systemic radiotherapy segment includes iobenguane (I-131), samarium-153, rhenium-186, and other radioisotopes (Yttrium-90, Radium-223, Phosphorous-32, and Radio-labelled antibodies, among others). In 2020, the particle therapy segment accounted for the largest growth rate, mainly due to the growing prevalence of cancer, continuous product development, and launches during last three years. For instance, Varian launched the ProBeam 360° single-room proton therapy system in 2018 and introduced a multi-room configuration for the same product in 2019. Similarly, Mevion received FDA 510(k) clearance for the MEVION S250i Proton Therapy System, including the HYPERSCAN pencil beam scanning (PBS) technology, in January 2018.

“Increasedinstallations and government initiativesto drive the segment growthof hospitals end user segment.”
Based on end user, the radiotherapy market has been segmented into hospitals and independent radiotherapy centers. The hospitals segment accounted for the largest share of the radiotherapy market owing to the rising global prevalence of cancer, increasing installations of advanced radiotherapy equipment in developed as well as developing regions, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced radiotherapy systems, and the increasing availability of funding for the adoption of advanced cancer treatment technologies.In 2021, Children’s Hospital of Fudan University, Shanghai and Shanghai Fosun Healthcare (Group) Co., Ltd. (China) signed an agreement with Mevion Medical Systems to establish the first pediatric proton therapy center in China. Many more such recent developments will drive the market for hospital end user segment.

“The US market, by region, commanded the largest market share in 2020.”
On the basis of region, the radiotherapy market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North America held the major share of the global radiotherapy market in 2020. The large share of the North American market can be attributed to factors such as the ongoing technological advancements, rising incidence of cancer, improving reimbursement scenario, and the rising focus of key players on strengthening their presence in the region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type:Tier 1–45%, Tier 2–34%, and Tier 3– 21%
• By Designation: C-level–47%, Director-level–33%, and Others–20%
• By Region:North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%

The dominant players in the global radiotherapy market are Varian Medical Systems, Inc. (US), Elekta (Sweden) Accuray Incorporated (US), Ion Beam Applications SA (Belgium), BD (US), Eckert & Ziegler (Germany), Hitachi Ltd. (Japan), ICAD, Inc. (US), IntraOp Medical, Inc. (US), IsoRay Medical, Inc. (US), Mevion Medical Systems, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel), ViewRay, Inc. (US), and ZEISS Group (Germany), among others.

Research Coverage:
This report studies the radiotherapymarket based onproduct, procedure, application, end user, and region. It also coversthe factors affecting market growth,analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report:
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration:Comprehensive information on the product portfolios offered by the top players in the radiotherapymarket
 Product Development/Innovation:Detailed insights on the upcoming trends, R&D activities, and product launches in the radiotherapymarket
 Market Development:Comprehensive information on lucrative emerging regions
 Market Diversification:Exhaustive information about new products, growing geographies, and recent developments in the radiotherapymarket
 Competitive Assessment:In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

【レポートの目次】

1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS & EXCLUSIONS 33
1.3 STUDY SCOPE 34
1.3.1 MARKETS COVERED 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY USED FOR THE STUDY 35
1.5 MARKET STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY DATA 38
2.1.2 PRIMARY DATA 39
FIGURE 2 BREAKDOWN OF PRIMARIES: RADIOTHERAPY MARKET 39
2.2 MARKET ESTIMATION METHODOLOGY 39
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 40
2.2.2 USAGE-BASED MARKET ESTIMATION 41
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL RADIOTHERAPY MARKET 41
2.2.3 PRIMARY RESEARCH VALIDATION 42
2.3 DATA TRIANGULATION 42
FIGURE 5 DATA TRIANGULATION 43
2.4 RESEARCH ASSUMPTIONS 44
2.5 RESEARCH LIMITATIONS 44
3 EXECUTIVE SUMMARY 45
FIGURE 6 RADIOTHERAPY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 45
FIGURE 7 EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 46
FIGURE 8 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET,
BY PROCEDURE, 2021 VS. 2026 (USD MILLION) 47
FIGURE 9 RADIOTHERAPY MARKET SHARE, BY END USER, 2021 VS. 2026 47
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE RADIOTHERAPY MARKET 48
4 PREMIUM INSIGHTS 49
4.1 RADIOTHERAPY MARKET OVERVIEW 49
FIGURE 11 RISING CANCER PREVALENCE ACROSS THE GLOBE TO DRIVE THE
GROWTH OF THE RADIOTHERAPY MARKET 49
4.2 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT AND REGION 50
FIGURE 12 LINER ACCELERATORS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE
OF THE EUROPEAN MARKET 50
4.3 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 51
FIGURE 13 PROSTATE CANCER TREATMENT IS THE LARGEST APPLICATION OF
INTERNAL BEAM RADIOTHERAPY IN NORTH AMERICA 51
4.4 GEOGRAPHIC SNAPSHOT OF THE RADIOTHERAPY MARKET 52
FIGURE 14 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 15 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 Technological advancements 54
5.2.1.2 Expansion of the target patient population 55
5.2.1.3 Increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy 55
5.2.1.4 Growing use of particle therapy for cancer treatment 56
5.2.2 KEY MARKET RESTRAINTS 60
5.2.2.1 Lack of adequate healthcare infrastructure 60
5.2.2.2 Shortage of skilled oncologists/radiologists 60
5.2.2.3 Affordability and accessibility of treatment 61
5.2.2.4 Complex nature of radiotherapy 61
5.2.3 KEY MARKET OPPORTUNITIES 61
5.2.3.1 Rising healthcare expenditure across developing countries 61
5.2.3.2 Growing government and private investments to meet the increasing demand for cancer treatment 62
5.2.4 CHALLENGES 63
5.2.4.1 Difficulties in visualizing tumors during radiotherapy procedures 63
5.2.4.2 Risk of radiation exposure 63
5.3 PORTER’S FIVE FORCES ANALYSIS 63
5.3.1 OVERVIEW 63
TABLE 1 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 64
5.3.2 THREAT OF NEW ENTRANTS 64
FIGURE 16 THREAT OF NEW ENTRANTS 64
5.3.3 THREAT OF SUBSTITUTES 65
FIGURE 17 THREAT OF SUBSTITUTES 65
5.3.4 BARGAINING POWER OF SUPPLIERS 65
FIGURE 18 BARGAINING POWER OF SUPPLIERS 65
5.3.5 BARGAINING POWER OF BUYERS 66
FIGURE 19 BARGAINING POWER OF BUYERS 66
5.3.6 DEGREE OF COMPETITION 66
FIGURE 20 DEGREE OF COMPETITION 66
5.4 REGULATORY SCENARIO 67
5.4.1 US 67
TABLE 2 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
5.4.2 EUROPE 68
5.4.3 JAPAN 68
TABLE 3 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 69
5.4.4 EMERGING COUNTRIES 69
5.5 REIMBURSEMENT SCENARIO 70
TABLE 4 REIMBURSEMENT CODES FOR RADIOTHERAPY AND RELATED PROCEDURES 70
5.6 ECOSYSTEM COVERAGE 71
5.7 VALUE CHAIN ANALYSIS 72
5.8 COVID-19 IMPACT ON THE RADIOTHERAPY MARKET 72
5.9 PRICING ANALYSIS 73
5.10 PATENT ANALYSIS 74
5.10.1 PATENT DETAILS 74
FIGURE 21 PATENT ANALYSIS, JANUARY 2011–MARCH 2021 75
6 RADIOTHERAPY MARKET, BY PRODUCT 76
6.1 INTRODUCTION 77
TABLE 5 RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 77
6.2 EXTERNAL BEAM RADIOTHERAPY PRODUCTS 77
TABLE 6 EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 78
TABLE 7 EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY REGION,
2019–2026 (USD MILLION) 78
6.2.1 LINEAR ACCELERATORS 79
TABLE 8 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 79
TABLE 9 LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 79
6.2.2 CONVENTIONAL LINEAR ACCELERATORS 80
6.2.2.1 Lower equipment and maintenance cost will drive the market for conventional LINACs 80
TABLE 10 CONVENTIONAL LINEAR ACCELERATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 80
6.2.3 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS 80
TABLE 11 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 81
TABLE 12 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 81
6.2.3.1 Cyberknife 82
6.2.3.1.1 CyberKnife offers a precise radiation delivery method with specialized tracking and robotic correction capabilities 82
TABLE 13 CYBERKNIFE MARKET, BY REGION, 2019–2026 (USD MILLION) 82
6.2.3.2 Gamma knife 83
6.2.3.2.1 Gamma Knife offers promising results for brain
metastasis patients 83
TABLE 14 GAMMA KNIFE MARKET, BY REGION, 2019–2026 (USD MILLION) 83
6.2.3.3 Tomotherapy 84
6.2.3.3.1 Continuous product development and launches adding
to the growth prospects of this market segment 84
TABLE 15 TOMOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION) 84
6.2.4 PARTICLE THERAPY SYSTEMS 84
TABLE 16 PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 85
TABLE 17 PARTICLE THERAPY SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 85
6.2.4.1 Cyclotrons 86
6.2.4.1.1 Leading players in the particle therapy market mainly manufacture cyclotrons 86
TABLE 18 CYCLOTRONS MARKET, BY REGION, 2019–2026 (USD MILLION) 86
6.2.4.2 Synchrotrons 86
6.2.4.2.1 Increasing investments for the development of synchrotron facilities are contributing to market growth 86
TABLE 19 SYNCHROTRONS MARKET, BY REGION, 2019–2026 (USD MILLION) 87
6.2.4.3 Synchrocyclotrons 87
6.2.4.3.1 High space requirements of synchrocyclotrons are
limiting their widespread adoption 87
TABLE 20 SYNCHROCYCLOTRONS MARKET, BY REGION, 2019–2026 (USD MILLION) 88
6.2.5 CONVENTIONAL COBALT-60 TELETHERAPY UNITS 88
6.2.5.1 High cost and risk of radiation exposure with cobalt-60 radio isotopes have hindered the growth of this segment 88
TABLE 21 CONVENTIONAL COBALT-60 TELETHERAPY UNITS MARKET, BY REGION, 2019–2026 (USD MILLION) 89
6.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS 89
TABLE 22 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 90
TABLE 23 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET,
BY REGION, 2019–2026 (USD MILLION) 90
6.3.1 SEEDS 91
6.3.1.1 Adverse side-effects associated with seeds limit their adoption 91
TABLE 24 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY SEEDS MARKET,
BY REGION, 2019–2026 (USD MILLION) 91
6.3.2 APPLICATORS 92
6.3.2.1 Manual applicators pose a high risk of radiation exposure
to the patients and staff 92
TABLE 25 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 92
6.3.3 AFTERLOADERS 93
6.3.3.1 Modern afterloaders offer proper positioning and better control
of isotopes inside the body of patients 93
TABLE 26 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY AFTERLOADERS
MARKET, BY REGION, 2019–2026 (USD MILLION) 93
6.3.4 IORT SYSTEMS 94
6.3.4.1 Growing adoption of electronic brachytherapy procedures to support the growth of this market segment 94
TABLE 27 IORT SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 94
6.4 SYSTEMIC RADIOTHERAPY 95
6.4.1 IOBENGUANE (I-131) 95
6.4.2 SAMARIUM-153 95
6.4.3 RHENIUM-186 96
6.4.4 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS 96
7 RADIOTHERAPY MARKET, BY APPLICATION 97
7.1 INTRODUCTION 98
TABLE 28 RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 98
7.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS 99
TABLE 29 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 99
TABLE 30 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION) 99
7.2.1 PROSTATE CANCER 100
7.2.1.1 High incidence rate and efficiency of EBRT for prostate cancer treatment to drive the growth of this market segment 100
TABLE 31 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER,
BY REGION, 2019–2026 (USD MILLION) 100
7.2.2 BREAST CANCER 101
7.2.2.1 Therapeutic benefits of EBRT for breast cancer over other treatments to drive the growth of this market segment 101
TABLE 32 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2019–2026 (USD MILLION) 101
7.2.3 LUNG CANCER 102
7.2.3.1 Radiotherapy can be used as an adjuvant therapy with surgical procedures or chemotherapy or as a curative therapy for lung cancer 102
TABLE 33 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2019–2026 (USD MILLION) 102
7.2.4 HEAD & NECK CANCER 103
7.2.4.1 Benefits of EBRT will increase its use in head and neck
cancer treatment 103
TABLE 34 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER,
BY REGION, 2019–2026 (USD MILLION) 103
7.2.5 COLORECTAL CANCER 104
7.2.5.1 Availability of alternative therapeutic options to limit the growth
of this market segment 104
TABLE 35 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER,
BY REGION, 2019–2026 (USD MILLION) 104
7.2.6 OTHER CANCERS 105
TABLE 36 EXTERNAL BEAM RADIOTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2019–2026 (USD MILLION) 105
7.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS 106
TABLE 37 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 38 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION) 106
7.3.1 PROSTATE CANCER 107
7.3.1.1 Precision and rapidity of brachytherapy in prostate cancer treatment to drive the growth of this market segment 107
TABLE 39 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2019–2026 (USD MILLION) 107
7.3.2 GYNECOLOGICAL CANCER 108
7.3.2.1 Availability of alternatives to hinder the adoption of brachytherapy
in gynecological cancer treatment 108
TABLE 40 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2019–2026 (USD MILLION) 108
7.3.3 BREAST CANCER 109
7.3.3.1 Precision and rapidity of brachytherapy treatment are driving
its use in breast cancer applications 109
TABLE 41 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR
BREAST CANCER, BY REGION, 2019–2026 (USD MILLION) 109
7.3.4 CERVICAL CANCER 110
7.3.4.1 Brachytherapy is an important part of the treatment of cervical cancer patients when radiation therapy is the primary choice of curative treatment 110
TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2019–2026 (USD MILLION) 110
7.3.5 PENILE CANCER 111
7.3.5.1 Interstitial brachytherapy is the standard conservative therapy
for localized penile cancer 111
TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2019–2026 (USD MILLION) 111
7.3.6 OTHER CANCERS 112
TABLE 44 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2019–2026 (USD MILLION) 112
8 RADIOTHERAPY MARKET, BY PROCEDURE 113
8.1 INTRODUCTION 114
TABLE 45 RADIOTHERAPY MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 114
8.2 EXTERNAL BEAM RADIOTHERAPY 115
TABLE 46 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 47 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION,
2019–2026 (USD MILLION) 115
8.3 IMAGE-GUIDED RADIOTHERAPY 116
TABLE 48 IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION,
2019–2026 (USD MILLION) 116
8.3.1 INTENSITY-MODULATED RADIOTHERAPY 117
8.3.1.1 The radiation intensity of each beam in IMRT is controlled, and the beam shape changes throughout each treatment. 117
TABLE 49 INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION,
2019–2026 (USD MILLION) 117
8.3.2 3D CONFORMAL RADIOTHERAPY 118
8.3.2.1 Multiple beams with 3D-CRT allow precise radiation conforming
to the tumor shape and size 118
TABLE 50 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION,
2019–2026 (USD MILLION) 118
8.3.3 STEREOTACTIC THERAPY 119
8.3.3.1 Stereotactic therapy offers a minimally invasive alternative to ablation surgeries 119
TABLE 51 STEREOTACTIC THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION) 119
8.3.4 PARTICLE THERAPY 120
8.3.4.1 Adoption of particle therapy as the primary mode of cancer
treatment is increasing 120
TABLE 52 PARTICLE THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION) 120
8.4 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY 121
TABLE 53 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 54 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION) 121
8.4.1 HIGH-DOSE-RATE BRACHYTHERAPY 122
8.4.1.1 Electronic brachytherapy is one of the recent advancements
in this technique 122
TABLE 55 HIGH-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION,
2019–2026 (USD MILLION) 122
8.4.2 LOW-DOSE-RATE BRACHYTHERAPY 123
8.4.2.1 Lower risk of radiation exposure to the surrounding tissues
to support the growth of this market segment 123
TABLE 56 LOW-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION,
2019–2026 (USD MILLION) 123
8.4.3 PULSED-DOSE-RATE BRACHYTHERAPY 124
8.4.3.1 Pulsed-dose-rate brachytherapy combines the advantages
of HDR and LDR brachytherapy 124
TABLE 57 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION,
2019–2026 (USD MILLION) 124
8.5 SYSTEMIC RADIOTHERAPY 124
8.5.1 INTRAVENOUS RADIOTHERAPY 125
8.5.2 ORAL RADIOTHERAPY 125
8.5.3 INSTILLATION RADIOTHERAPY 125

9 RADIOTHERAPY MARKET, BY END USER 126
9.1 INTRODUCTION 127
TABLE 58 RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION) 127
9.2 HOSPITALS 128
9.2.1 INCREASING NUMBER OF SUPPLY DEALS OF ADVANCED RADIOTHERAPY PRODUCTS BETWEEN COMPANIES AND HOSPITALS TO DRIVE
MARKET GROWTH 128
TABLE 59 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION,
2019–2026 (USD MILLION) 128
9.3 INDEPENDENT RADIOTHERAPY CENTERS 129
9.3.1 RISING CONSOLIDATION OF HEALTHCARE NETWORKS IS CHALLENGING
THE GROWTH OF FREE-STANDING RADIOTHERAPY CENTERS 129
TABLE 60 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS,
BY REGION, 2019–2026 (USD MILLION) 129
10 RADIOTHERAPY MARKET, BY REGION 130
10.1 INTRODUCTION 131
TABLE 61 RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION) 131
10.2 NORTH AMERICA 132
FIGURE 22 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT 132
TABLE 62 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
TABLE 63 NORTH AMERICA: RADIOTHERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 133
TABLE 64 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 65 NORTH AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 66 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 67 NORTH AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 68 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 135
TABLE 69 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 70 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 71 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET,
BY APPLICATION, 019–2026 (USD MILLION) 136
TABLE 72 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 137
TABLE 73 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER,
2019–2026 (USD MILLION) 137
10.2.1 US 137
10.2.1.1 Changes in the reimbursement scenario to drive market
growth in the US 137
TABLE 74 US: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 138
TABLE 75 US: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 139
TABLE 76 US: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 77 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
10.2.2 CANADA 140
10.2.2.1 Increasing incidence of cancer to drive market growth in Canada 140
TABLE 78 CANADA: RADIOTHERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 141
TABLE 79 CANADA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 80 CANADA: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 81 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
10.3 EUROPE 142
TABLE 82 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 143
TABLE 83 EUROPE: RADIOTHERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 143
TABLE 84 EUROPE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 85 EUROPE: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 86 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 87 EUROPE: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 88 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 89 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 90 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET,
BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 91 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 146
TABLE 92 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 147
TABLE 93 EUROPE: RADIOTHERAPY MARKET, BY END USER,
2019–2026 (USD MILLION) 147
10.3.1 GERMANY 148
10.3.1.1 Germany is the largest market for radiotherapy in Europe 148
TABLE 94 GERMANY: RADIOTHERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 149
TABLE 95 GERMANY: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 96 GERMANY: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 97 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 150
10.3.2 FRANCE 150
10.3.2.1 High healthcare expenditure in France to drive market growth 150
TABLE 98 FRANCE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 150
TABLE 99 FRANCE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 100 FRANCE: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 101 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 151
10.3.3 UK 152
10.3.3.1 Increasing prevalence of cancer to drive market growth in the UK 152
TABLE 102 UK: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 152
TABLE 103 UK: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 104 UK: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 105 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
10.3.4 SPAIN 154
10.3.4.1 Increasing number of conferences and government funding for cancer research to drive market growth in Spain 154
TABLE 106 SPAIN: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 155
TABLE 107 SPAIN: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 108 SPAIN: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 109 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 156
10.3.5 ITALY 156
10.3.5.1 Increasing awareness activities to support market growth 156
TABLE 110 ITALY: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 157
TABLE 111 ITALY: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 112 ITALY: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 113 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 158
10.3.6 REST OF EUROPE 158
TABLE 114 ROE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 158
TABLE 115 ROE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 116 ROE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 117 ROE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
10.4 ASIA PACIFIC 160
FIGURE 23 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT 161
TABLE 118 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
TABLE 119 ASIA PACIFIC: RADIOTHERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 162
TABLE 120 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 121 ASIA PACIFIC: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 122 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 123 ASIA PACIFIC: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 124 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 125 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 126 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 127 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 165
TABLE 128 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 166
TABLE 129 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER,
2019–2026 (USD MILLION) 166
10.4.1 JAPAN 166
10.4.1.1 Rising geriatric population and subsequent increase in the prevalence of cancer to drive market growth in Japan 166
TABLE 130 JAPAN: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 167
TABLE 131 JAPAN: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 132 JAPAN: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 133 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 168
10.4.2 CHINA 168
10.4.2.1 Increasing number of strategic partnerships and supply
deals to drive market growth 168
TABLE 134 CHINA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 169
TABLE 135 CHINA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 169
TABLE 136 CHINA: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 137 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 170
10.4.3 INDIA 170
10.4.3.1 High need for radiotherapy systems in the country is expected
to offer growth opportunities to market players 170
TABLE 138 INDIA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 171
TABLE 139 INDIA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 140 INDIA: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 141 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 172
10.4.4 SOUTH KOREA 172
10.4.4.1 Increasing incidence of cancer to drive market growth in South Korea 172
TABLE 142 SOUTH KOREA: RADIOTHERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 173
TABLE 143 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 144 SOUTH KOREA: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 145 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 174
10.4.5 AUSTRALIA 174
10.4.5.1 Increasing prevalence of cancer to drive market growth in Australia 174
TABLE 146 AUSTRALIA: RADIOTHERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 174
TABLE 147 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 148 AUSTRALIA: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 149 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
10.4.6 REST OF ASIA PACIFIC 176
TABLE 150 ROAPAC: RADIOTHERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 176
TABLE 151 ROAPAC: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 177
TABLE 152 ROAPAC: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 153 ROAPAC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 177
10.5 LATIN AMERICA 178
TABLE 154 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 178
TABLE 155 LATIN AMERICA: RADIOTHERAPY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 178
TABLE 156 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 157 LATIN AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 158 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 159 LATIN AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 160 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 161 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 162 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 163 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 182
TABLE 164 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 182
TABLE 165 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER,
2019–2026 (USD MILLION) 183
10.5.1 BRAZIL 183
10.5.1.1 Increasing cancer incidence to drive market growth in Brazil 183
TABLE 166 BRAZIL: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 183
TABLE 167 BRAZIL: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 168 BRAZIL: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 169 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
10.5.2 MEXICO 185
10.5.2.1 Increasing awareness programs fueling market growth in Mexico 185
TABLE 170 MEXICO: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 185
TABLE 171 MEXICO: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 172 MEXICO: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 173 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
10.5.3 REST OF LATIN AMERICA 187
TABLE 174 ROLA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 187
TABLE 175 ROLA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 176 ROLA: LINEAR ACCELERATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 177 ROLA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
10.6 MIDDLE EAST & AFRICA 189
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA 189
TABLE 178 MEA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 179 MEA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 180 MEA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 181 MEA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 182 MEA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 183 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 184 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 185 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 186 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 193
TABLE 187 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 193
TABLE 188 MEA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION) 194
11 COMPETITIVE LANDSCAPE 195
11.1 OVERVIEW 195
FIGURE 24 KEY DEVELOPMENTS IN THE RADIOTHERAPY MARKET
(JANUARY 2018 TO MAY 2021) 195
11.2 MARKET SHARE ANALYSIS 196
11.2.1 GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS (2020) 196
FIGURE 25 GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER (2020) 196
11.3 COMPANY EVALUATION QUADRANT 196
11.3.1 STARS 197
11.3.2 EMERGING LEADERS 197
11.3.3 PERVASIVE PLAYERS 197
11.3.4 PARTICIPANTS 197
FIGURE 26 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 198
FIGURE 27 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2020) 199
11.4 COMPETITIVE SCENARIO 200
11.4.1 PRODUCT LAUNCHES AND APPROVALS 200
TABLE 189 RADIOTHERAPY MARKET: KEY PRODUCT LAUNCHES AND APPROVALS, JANUARY 2018 TO MAY 2021 200
11.4.2 EXPANSIONS 200
TABLE 190 RADIOTHERAPY MARKET: KEY EXPANSIONS, JANUARY 2018 TO MAY 2021 200
11.4.3 DEALS 201
TABLE 191 RADIOTHERAPY MARKET: KEY DEALS, JANUARY 2018 TO MAY 2021 201

12 COMPANY PROFILES 202
12.1 KEY PLAYERS 202
(Business Overview, Products Offered, Recent Developments, MnM view)*
12.1.1 VARIAN MEDICAL SYSTEMS, INC. 202
TABLE 192 VARIAN MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW 202
FIGURE 28 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 203
12.1.2 ELEKTA AB 210
TABLE 193 ELEKTA AB: BUSINESS OVERVIEW 210
FIGURE 29 ELEKTA AB: COMPANY SNAPSHOT 211
12.1.3 ACCURAY INCORPORATED 217
TABLE 194 ACCURAY INCORPORATED: BUSINESS OVERVIEW 217
FIGURE 30 ACCURAY INCORPORATED: COMPANY SNAPSHOT 218
12.1.4 BECTON, DICKINSON AND COMPANY 222
TABLE 195 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 222
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 223
12.1.5 IBA WORLDWIDE 224
TABLE 196 IBA WORLDWIDE: BUSINESS OVERVIEW 224
FIGURE 32 IBA WORLDWIDE: COMPANY SNAPSHOT 225
12.1.6 VIEWRAY, INC. 228
TABLE 197 VIEWRAY, INC.: BUSINESS OVERVIEW 228
FIGURE 33 VIEWRAY, INC.: COMPANY SNAPSHOT 229
12.1.7 ISORAY MEDICAL 231
TABLE 198 ISORAY MEDICAL: BUSINESS OVERVIEW 231
FIGURE 34 ISORAY MEDICAL, INC.: COMPANY SNAPSHOT 231
12.1.8 HITACHI LTD. 233
TABLE 199 HITACHI LTD.: BUSINESS OVERVIEW 233
FIGURE 35 HITACHI LTD.: COMPANY SNAPSHOT 234
12.1.9 PANACEA MEDICAL TECHNOLOGIES PVT. LTD. 236
TABLE 200 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW 236
12.1.10 PROVISION HEALTHCARE 237
TABLE 201 PROVISION HEALTHCARE: BUSINESS OVERVIEW 237
12.1.11 MEVION MEDICAL SYSTEMS 238
TABLE 202 MEVION MEDICAL SYSTEMS: BUSINESS OVERVIEW 238
12.1.12 OPTIVUS PROTON THERAPY, INC. 241
TABLE 203 OPTIVUS PROTON THERAPY: BUSINESS OVERVIEW 241
12.1.13 P-CURE 242
TABLE 204 P-CURE: BUSINESS OVERVIEW 242
12.1.14 SUMITOMO HEAVY INDUSTRIES LTD. 243
TABLE 205 SUMITOMO HEAVY INDUSTRIES LTD.: BUSINESS OVERVIEW 243
FIGURE 36 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT 244
TABLE 206 THERAGENICS CORPORATION: BUSINESS OVERVIEW 245
12.1.15 ZEISS GROUP 246
TABLE 207 ZEISS GROUP: BUSINESS OVERVIEW 246
FIGURE 37 ZEISS GROUP: COMPANY SNAPSHOT 247
12.2 OTHER PLAYERS 248
12.2.1 INTRAOP MEDICAL, INC. 248
12.2.2 ICAD, INC. 248
12.2.3 ECKERT & ZIEGLER 249
12.2.4 SENSUS HEALTHCARE 249
12.2.5 S.I.T SORDINA IORT TECHNOLOGIES S.P.A. 250
*Details on Business Overview, Products Offered, Recent Developments, MnM view might not be captured in case of unlisted companies.
13 APPENDIX 251
13.1 DISCUSSION GUIDE 251
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 256
13.3 AVAILABLE CUSTOMIZATIONS 258
13.4 RELATED REPORTS 258
13.5 AUTHOR DETAILS 259



★調査レポート[世界の放射線療法市場予測:製品別、処置別、用途別、エンドユーザー別] ( Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) - Global Forecasts to 2026 / MD1773) 販売に関する免責事項
[世界の放射線療法市場予測:製品別、処置別、用途別、エンドユーザー別] ( Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) - Global Forecasts to 2026 / MD1773) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆